Tigecyclin injection

About Tigecyclin injection

Tigecycline injection is a broad-spectrum antibiotic belonging to the glycylcycline class, primarily used for treating severe bacterial infections. It is effective against multidrug-resistant organisms, including Gram-positive, Gram-negative, and anaerobic bacteria. Tigecycline is commonly prescribed for complicated skin and soft tissue infections, intra-abdominal infections, and community-acquired pneumonia. Its efficacy against resistant pathogens, such as MRSA and Acinetobacter species, makes it a vital option in critical care settings. In veterinary applications, Tigecycline injection is utilized to manage serious infections in animals. With its wide antibacterial spectrum and ability to combat resistant strains, Tigecycline is a valuable tool in advanced infection management.

Indications and Clinical Use

Tigecycline injection is prescribed for complicated intra-abdominal infections and severe skin and skin structure infections. Its use is reserved for hospitals, ensuring that patients receive this potent antibiotic under expert medical supervision. Healthcare professionals rely on tigecycline for challenging cases to combat a broad range of resistant bacteria effectively.


Preparation and Administration

Before administration, Tigecycline must be properly reconstituted with 5.3 mL of 0.9% Sodium Chloride or 5% Dextrose Injection. The distinctly orange to yellow lyophilized cake ensures product recognition. Only trained hospital staff should handle this process using sterile technique to maintain drug efficacy and patient safety.


Storage and Shelf Life Guidelines

To preserve its effectiveness, Tigecycline injection should be stored below 25C, away from light exposure. The product maintains full potency for up to 24 months. Proper storage in hospital pharmacies or clinical settings is essential to prevent degradation and ensure safe, reliable treatment outcomes.